The developed world has an increasingly aging population, with approximately 10% of the population aged over 65 years. As the incidence and prevalence of blood disorders increases with age, these conditions are a heavy burden on healthcare systems.
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Part I Epidemiology
In Blood Disorders of the Elderly we propose a novel look at aging. By identifying the infl uence of aging on the development of blood disorders, and the infl uence of these disorders on the progression of aging, we acknowledge the dynamic, and to some extent circular, aspect of aging. Recognizing that the incidence and prevalence of blood disorders increases with age, we explore the possibility that the study of the blood may reveal an individual's age, and that the correction of blood disorders may limit the risk of aging-related events, including death, disease, and disability.
We elected to study blood disorders in the aged, because blood disorders are our area of expertise. Luckily, hematopoiesis and hemostasis are also a common crossroads of diseases and environmental stresses. So, it is not far-fetched to expect that the different events that contribute to individual aging leave their fi ngerprints on that individual's blood. It is well known, for example, that aging is associated with a progressive reduction of marrow cellularity, a progressive increase in the prevalence of myeloid dysplasia, and increased concentration of coagulation markers, such as the D-dimer, in the circulation. It is also well known that the hemoglobin levels and levels of circulating coagulation markers are related to the risk of death, disability, and cognitive decline.
Given the rapid accumulation of new information related both to blood disorders and to aging, and given the dynamic nature of aging, this book is conceived as a new clinical paradigm for physicians involved in the management of older patients, as a springboard for scientists interested in the biology of aging and its clinical consequences, and as an operating system able to organize incoming knowledge for students of biological, clinical, and social sciences.
The reception of this book will represent the best measure of our success in pursuing our goals. Irrespective of our personal success, however, we hope to have inspired other clinicians and scientists to take a new and novel look at aging that will be translated into new publications, new research projects, and new approaches to clinical practice.
We wish to thank Cambridge University Press for supporting this project, our coauthors for their hard work, and especially Anita Klamo for the diffi cult task of coordinating the different contributions.
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